REIN THERAPEUTICS INC (RNTX) Forecast, Price Target & Analyst Ratings

NASDAQ:RNTX • US00887A2042

Current stock price

1.25 USD
-0.02 (-1.57%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REIN THERAPEUTICS INC (RNTX).

Forecast Snapshot

Consensus Price Target

Price Target
$10.20
+ 716.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.22
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.20
Upside
+ 716.00%
From current price of $1.25 to mean target of $10.20, Based on 8 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50

Price Target Revisions

1 Month
0.00%
3 Months
25.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for RNTX. The average price target is 10.2 USD. This implies a price increase of 716% is expected in the next year compared to the current price of 1.25.
The average price target has been revised upward by 25% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RNTX Current Analyst RatingRNTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

RNTX Historical Analyst RatingsRNTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
RNTX was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RNTX.
In the previous month the buy percentage consensus was at a similar level.
RNTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-21Brookline CapitalDowngrade Buy -> Hold
2025-09-22HC Wainwright & Co.Initiate Buy
2025-08-19Brookline CapitalDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.22
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
90.03%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

RNTX is expected to report earnings on 4/6/2026. The consensus EPS estimate for the next earnings is -0.22 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RNTX revenue by date.RNTX revenue by date.
N/AN/AN/AN/AN/AN/AN/A
131.24%		N/A
44.50%		N/A
34.46%
EBITDA
YoY % growth
RNTX ebitda by date.RNTX ebitda by date.
-12.56M-17.94M
-42.83%		-22.88M
-27.54%		-31.68M
-38.46%		-29.8M
5.93%		-20.34M
31.74%		-26.49M
-30.24%		-27.48M
-3.74%		-15.229M
44.58%		-28.049M
-84.18%		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
RNTX ebit by date.RNTX ebit by date.
-12.89M-18.17M
-40.96%		-23.01M
-26.64%		-31.9M
-38.64%		-29.96M
6.08%		-20.5M
31.58%		-26.61M
-29.80%		-27.65M
-3.91%		-15.348M
44.49%		-28.112M
-83.16%		N/A
12.01%		N/A
-49.28%		N/A
-39.78%		N/A
-44.86%		N/A
3.41%		N/A
118.36%		N/A
295.00%		N/A
80.53%		N/A
46.60%
Operating Margin
RNTX operating margin by date.RNTX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
RNTX eps by date.RNTX eps by date.
N/AN/AN/A-41.20
15.10%		-25.80
37.38%		-12.60
51.16%		-5.80
53.97%		-6.02
-3.79%		N/A
65.91%		-3.78
-84.19%		N/A
74.23%		N/A
15.18%		N/A
-13.58%		N/AN/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		-0.22
90.03%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-6.375M
-9.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RNTX Yearly Revenue VS EstimatesRNTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 2032 2033 100M 200M 300M
RNTX Yearly EPS VS EstimatesRNTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30 -40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
20.55%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REIN THERAPEUTICS INC / RNTX Forecast FAQ

Can you provide the average price target for REIN THERAPEUTICS INC stock?

8 analysts have analysed RNTX and the average price target is 10.2 USD. This implies a price increase of 716% is expected in the next year compared to the current price of 1.25.

When does REIN THERAPEUTICS INC (RNTX) report earnings?

REIN THERAPEUTICS INC (RNTX) will report earnings on 2026-04-06, after the market close.

What are the consensus estimates for REIN THERAPEUTICS INC (RNTX) next earnings?

The consensus EPS estimate for the next earnings of REIN THERAPEUTICS INC (RNTX) is -0.22 USD and the consensus revenue estimate is 0 USD.

How many analysts cover REIN THERAPEUTICS INC (RNTX) stock?

The number of analysts covering REIN THERAPEUTICS INC (RNTX) is 8.